{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:56:03Z","timestamp":1790916963257,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    : Hepatic fibrosis (HF) is primarily driven by the activation of hepatic stellate cells (HSCs) and is characterized by excessive extracellular matrix (ECM) accumulation. Circular RNAs (circRNAs) have recently gained increasing attention in HF research.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    : RNA sequencing and bioinformatic analyses revealed elevated hsa_circ_0001377 expression in human HF tissues. Its circular structure and subcellular localization were identified using Sanger sequencing, RNase R treatment, and fluorescence\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization (FISH). Gain- and loss-of-function experiments were conducted to elucidate the role of hsa_circ_0001377 in the human HSC line LX-2. Furthermore, the\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    effects of the hsa_circ_0001377\/let-7a-5p\/TGFBR1, Smad2, and Col1a2 regulatory axis were investigated using cytological assays and a bile duct ligation (BDL)-induced mouse model of HF.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : hsa_circ_0001377 was significantly upregulated in the circRNA expression profile of human HF tissues. Its circular structure was validated through Sanger sequencing and resistance to RNase R digestion. FISH and co-staining with \u03b1-SMA demonstrated that hsa_circ_0001377 was abundantly expressed in activated HSCs (aHSCs; \u03b1-SMA-positive cells). Gain- and loss-of-function assays were performed using LX-2 cells with stable hsa_circ_0001377 overexpression and a specific siRNA targeting this circRNA. hsa_circ_0001377 overexpression promoted LX-2 cell activation, proliferation, migration, and G1\/S-phase transition, whereas its knockdown produced the opposite effects. qRT-PCR, AGO-RIP, dual-luciferase reporter, and miRNA pulldown assays confirmed that hsa_circ_0001377 acts as a molecular sponge for let-7a-5p and that let-7a-5p targets TGFBR1, Smad2, and Col1a2. Rescue experiments in LX-2 cells further demonstrated that hsa_circ_0001377 promotes HSC activation, proliferation, migration, and G1\/S-phase transition through the let-7a-5p\/TGFBR1, Smad2, and Col1a2 axis. Moreover, hsa_circ_0001377 was highly expressed in 20 human HF samples, and its expression increased with advancing fibrosis stage.\n                    <jats:italic>In vivo<\/jats:italic>\n                    , a BDL-induced murine HF model demonstrated that the homologous mmu_circ_0001377 was also significantly upregulated in fibrotic liver tissues. In addition, tail-vein injection of an mmu-let-7a-5p agomir into BDL-induced HF mice confirmed the inhibitory effects of the let-7a-5p\/TGFBR1, Smad2, and Col1a2 axis on \u03b1-SMA expression and collagen deposition.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Taken together, these findings suggest that the hsa_circ_0001377\/let-7a-5p\/TGFBR1, Smad2, and Col1a2 regulatory axis may represent a promising therapeutic target for HF.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1882205","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:38:10Z","timestamp":1790915890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["hsa_circ_0001377 promotes hepatic fibrosis by sponging let-7a-5p and targeting TGFBR1, Smad2, and Col1a2"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiaming","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]},{"name":"Department of Pathology, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3760\/cma.j.cn501113-20210119-00033","article-title":"Regulatory effects of microRNAs on hepatic stellate cell activation and liver fibrogenesis","volume":"29","author":"Abidan","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol. Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105009313","DOI":"10.3389\/fphar.2022.1050093","article-title":"Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p\/Col1a1 axis","volume":"13","author":"Binbin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Carl-Henrik","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/hepr.12871","article-title":"Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases","volume":"47","author":"Chen","year":"2017","journal-title":"Hepatol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/JCMA.0000000000000230","article-title":"CircularRNA as novel biomarkers in liver diseases","volume":"83","author":"Chien","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/nar\/gkw027","article-title":"Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2","volume":"44","author":"Du","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.18632\/oncotarget.3469","article-title":"Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt\/\u03b2-catenin pathway","volume":"6","author":"Fang","year":"2015","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis -- overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000374098","article-title":"Hepatic fibrosis: emerging therapies","volume":"33","author":"Friedman","year":"2015","journal-title":"Dig. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3748\/wjg.v24.i3.323","article-title":"circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling","volume":"24","author":"Guo","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression","volume":"66","author":"Han","year":"2017","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fphys.2012.00053","article-title":"Differential regulation of TGF-\u03b2\/Smad signaling in hepatic stellate cells between acute and chronic liver injuries","volume":"3","author":"Katsunori","year":"2012","journal-title":"Front. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0168-8278(02)00272-6","article-title":"Pirfenidone effectively reverses experimental liver fibrosis","volume":"37","author":"Leonel","year":"2002","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.18632\/aging.103257","article-title":"hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p\/TEP1 axis","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Lin","year":"2018","journal-title":"Biomed. Pharmacother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34643","DOI":"10.3389\/fmed.2021.734643","article-title":"Long non-coding RNA MALAT1: a key player in liver diseases","volume":"8","author":"Lu","year":"2021","journal-title":"Front. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-0037-1605371","article-title":"Epigenetics in liver fibrosis","volume":"37","author":"Massey","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.ymthe.2022.01.045","article-title":"hnRNPL-activated circANKRD42 back-splicing and circANKRD42-mediated crosstalk of mechanical stiffness and biochemical signal in lung fibrosis","volume":"30","author":"Pan","year":"2022","journal-title":"Mol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","article-title":"Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs","volume":"7","author":"Qiupeng","year":"2016","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/1566523219666191107113046","article-title":"Non-coding RNA associated competitive endogenous RNA regulatory network: novel therapeutic approach in liver fibrosis","volume":"19","author":"Riaz","year":"2019","journal-title":"Curr. Gene Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Sebastian","year":"2013","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1248\/bpb.b19-00901","article-title":"circACTR2: a novel mechanism regulating high glucose-induced fibrosis in renal tubular cells via pyroptosis","volume":"43","author":"Si","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Tatiana","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Thomas","year":"2013","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fgene.2020.00428","article-title":"Corrigendum: epigenetics and metabolism in health and disease","volume":"11","author":"Tzika","year":"2020","journal-title":"Front. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Valery","year":"2008","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ki.2013.372","article-title":"Transforming growth factor-\u03b21-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b","volume":"85","author":"Wang","year":"2014","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1111\/jcmm.14432","article-title":"CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6960941","DOI":"10.1155\/2020\/6960941","article-title":"Let-7c-5p is involved in chronic kidney disease by targeting TGF- \u03b2 signaling","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.addr.2017.10.011","article-title":"Epigenetic reprogramming in liver fibrosis and cancer","volume":"121","author":"Wilson","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/jnci\/djx166","article-title":"Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis","volume":"110","author":"Yang","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"B36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41388-017-0019-9","article-title":"A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cancergen.2011.03.007","article-title":"An insertion\/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population","volume":"204","author":"Zhansheng","year":"2011","journal-title":"Cancer Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1159\/000495556","article-title":"Thymosin-\u03b24 mediates hepatic stellate cell activation by interfering with CircRNA-0067835\/miR-155\/FoxO3 signaling pathway","volume":"51","author":"Zhu","year":"2018","journal-title":"Cell Physiol. Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1882205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:38:12Z","timestamp":1790915892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1882205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":40,"alternative-id":["10.3389\/fphar.2026.1882205"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1882205","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1882205"}}